Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Oct;27(10):3717-3727.
doi: 10.1007/s00520-019-04907-w. Epub 2019 Jun 28.

Psychostimulants for cancer-related cognitive impairment in adult cancer survivors: a systematic review and meta-analysis

Nadia Miladi  1 , Richi Dossa  1 , Maman Joyce Dogba  1 , Marie Immacula Fabienne Cléophat-Jolicoeur  1 , Bruno Gagnon  2
Affiliations
Meta-Analysis

Psychostimulants for cancer-related cognitive impairment in adult cancer survivors: a systematic review and meta-analysis

Nadia Miladi et al. Support Care Cancer. 2019 Oct.

Abstract

Background: Cognitive impairment is recognized as a common symptom experienced by cancer survivors which impacts on quality of life (QoL) and day-to-day activities. One of the treatment options is the use of psychostimulants but the evidence supporting its use remains unclear.

Objectives: To identify the level of evidence of psychostimulants' effect on the management of cognitive impairment in adult cancer survivors.

Methods: Electronic databases (MEDLINE, EMBASE, CENTRAL, CINAHL) and reference lists of relevant reviews were searched from inception to December 2017, with no language restrictions applied. Randomized controlled trials (RCTs), evaluating the effect of psychostimulants on cognitive impairment among cancer patients with no primary or secondary brain tumor or brain radiation, were included. The primary outcome was cognitive function changes, whereas secondary outcomes were adverse events (AEs) and QoL.

Results: Six RCTs were included: three studies investigating methylphenidate and three modafinil, with a total of 244 and 146 patients, respectively. Due to important differences in methodologies between studies, a meta-analysis was assumed inappropriate for the primary outcome. A narrative synthesis was performed. One study using methylphenidate and two using modafinil demonstrated improvements in some cognitive functions as measured by objective cognitive assessment tests. Psychostimulants did not improve QoL and were not associated with more AEs.

Conclusion: To date, limited evidence is available to estimate the usefulness (or lack) of psychostimulants on cognitive function in this population.

Keywords: Cancer; Cognitive impairment; Psychostimulants; Survivorship.

PubMed Disclaimer

References

    1. Canadian Cancer Statistics. http://www.cancer.ca [Internet]. 2016. Accessed 17 June 2019.
    1. Treanor C, Santin O, Mills M, Donnelly M (2013) Cancer survivors with self-reported late effects: their health status, care needs and service utilisation. Psycho-oncology. 22(11):2428–2435 - DOI - PubMed
    1. Jansen CE, Cancer Basics J, Eggert I (eds) (2010) Pittsburgh, PA: oncology nursing. society.
    1. Von AD, Jansen C, Allen DH, Schiavone RM, Wulff J (2011) Putting evidence into practice: evidence-based interventions for cancer and cancer treatment-related cognitive impairment. Clin J Oncol Nurs 15(6):607–615 - DOI
    1. Wefel JS, Kesler SR, Noll KR, Schagen SB (2015) Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin 65(2):123–138 - DOI - PubMed

MeSH terms

LinkOut - more resources